| Mon, Nov 2, 2009 | | • | Positive Phase III Data On XIFAXAN Will Drive Transformation Of Small GI Company According To Award Winning Piper Jaffrey Analyst
Wall Street Transcript (Mon, Nov 2)
| | • | Swine Flu Stock Picking Rewards Winners Handsomely
Indie Research (Mon, Nov 2)
| | • | Gilead Sciences Announces Plans for Phase IV Clinical Trial Evaluating First-Line Combination Therapy Versus Monotherapy in Pulmonary Arterial Hypertension
Business Wire (Mon, Nov 2)
| | • | Biotech Calendar: Key Dates for November
at TheStreet.com (Mon, Nov 2)
| | • | Peter Brimelow: Turnaround Letter not for faint of heart
at MarketWatch (Mon, Nov 2)
| | Sat, Oct 31, 2009 | | • | Gilead Announces Long-Term Data from Two Pivotal Phase III Studies Evaluating Viread® For Chronic Hepatitis B
Business Wire (Sat, Oct 31)
| | • | Obamacare PASS! The One Stock to Buy
at Motley Fool (Sat, Oct 31)
| | Fri, Oct 30, 2009 | | • | Gilead: Transforming AIDS
at Forbes.com (Fri, Oct 30)
| | • | Gilead Sciences to Present at the Oppenheimer 20th Annual Healthcare Conference on Tuesday, November 3
Business Wire (Fri, Oct 30)
| | • | Biotech Mailbag: The Reason(s) for This Selloff
at TheStreet.com (Fri, Oct 30)
| | Thu, Oct 29, 2009 | | • | Two Fools Featured in Barron's
at Motley Fool (Thu, Oct 29)
| | Wed, Oct 28, 2009 | | • | Saved by Emerging Markets. Sort Of.
at Motley Fool (Wed, Oct 28)
| | • | Trading Outlook for Incyte Corp. Issued by StockPreacher.com
GlobeNewswire (Wed, Oct 28)
| | Tue, Oct 27, 2009 | | • | 'Mad Money Lightning Round': QLogic's on Fire
at TheStreet.com (Tue, Oct 27)
| | • | Cramer's 'Mad Money' Recap: Tricks of the Trade (Final)
at TheStreet.com (Tue, Oct 27)
| | • | Cramer's 'Mad Money' Recap: Tricks of the Trade (Update 3)
at TheStreet.com (Tue, Oct 27)
| | • | The Bull and Bear Story on GTx's Pending Drug Decision: BioBuzz
at TheStreet.com (Tue, Oct 27)
| | • | The Bull and Bear Story on GTx's Pending Drug Approval: BioBuzz
at TheStreet.com (Tue, Oct 27)
| | • | Big-Cap Biotech Worries Lead Sector Down: BioBuzz
at TheStreet.com (Tue, Oct 27)
| | • | Trading Outlook for Elan Corp. Plc. Issued by InvestorSoup.com
GlobeNewswire (Tue, Oct 27)
| | Mon, Oct 26, 2009 | | • | Phase III Trial Expenses For Diabetes Treatments Now Forcing Acquisitions Of Small Cap Biotech Firms: FDA Has "Raised The Bar" For Approval Due To Recent Cardiovascular Issues
Wall Street Transcript (Mon, Oct 26)
| | • | Swine Flu Small-Cap Jumps on FDA Announcement
Indie Research (Mon, Oct 26)
| | • | Gilead's Aztreonam for Inhalation Solution to be Reviewed by FDA Anti-Infective Drugs Advisory Committee on December 10, 2009
Business Wire (Mon, Oct 26)
| | Sun, Oct 25, 2009 | | • | J&J wants deals with rivals to share risk
at FT.com (Sun, Oct 25)
| | • | The Next Home Run Stock
at Motley Fool (Sun, Oct 25)
|
Add GILD News to My Yahoo!:
 
| |
|
0.51% Nasdaq 
0.01 (0.02%) 
Headlines
